ChiCTR2400091059 版本V1.0 版本创建时间2024/10/20 01:00:59 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400091059 

最近更新日期:

Date of Last Refreshed on:

2024-10-20 01:00:35 

注册时间:

Date of Registration:

2024-10-20 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

一种新型骨修复材料的小样本临床预试验研究--丝氨酸修饰明胶海绵

Public title:

Small sample clinical pretrial study on a novel bone repair material -- serine modified gelatin sponge

注册题目简写:

English Acronym:

研究课题的正式科学名称:

一种新型骨修复材料的小样本临床预试验研究--丝氨酸修饰明胶海绵

Scientific title:

A small sample clinical pretrial study to evaluate a novel bone repair material, serine modified gelatin sponge

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

曹锋 

研究负责人:

蔡卜磊 

Applicant:

Feng Cao 

Study leader:

Bolei Cai 

申请注册联系人电话:

Applicant telephone:

+86 188 2179 3299

研究负责人电话:

Study leader's telephone:

+86 136 0928 1084

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

18840303173@163.com

研究负责人电子邮件:

Study leader's E-mail:

caibolei1020@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

陕西省西安市新城区长乐西路145号

研究负责人通讯地址:

陕西省西安市新城区长乐西路145号

Applicant address:

No. 145, Changle West Road, Xincheng District, Xi'an City, Shaanxi Province

Study leader's address:

No. 145, Changle West Road, Xincheng District, Xi'an City, Shaanxi Province

申请注册联系人邮政编码:

Applicant postcode:

726405

研究负责人邮政编码:

Study leader's postcode:

726405

申请人所在单位:

空军军医大学第三附属医院

Applicant's institution:

Air Force Medical University

研究负责人所在单位:

空军军医大学第三附属医院

Affiliation of the Leader:

Air Force Medical University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

KQ-YJ-2024-200

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

空军军医大学第三附属医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of the Third Hospital Affiliated to Air Force Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2024-09-09 00:00:00

伦理委员会联系人:

宋雅

Contact Name of the ethic committee:

Ya Song

伦理委员会联系地址:

陕西省西安市新城区长乐西路145号

Contact Address of the ethic committee:

No. 145, Changle West Road, Xincheng District, Xi'an City, Shaanxi Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 29 8477 6082

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

空军军医大学第三附属医院

Primary sponsor:

Air Force Medical University

研究实施负责(组长)单位地址:

陕西省西安市新城区长乐西路145号

Primary sponsor's address:

No. 145, Changle West Road, Xincheng District, Xi'an City, Shaanxi Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

陕西

市(区县):

Country:

China

Province:

Shaanxi

City:

单位(医院):

空军军医大学第三附属医院

具体地址:

陕西省西安市新城区长乐西路145号

Institution
hospital:

Air Force Medical University

Address:

No. 145, Changle West Road, Xincheng District, Xi'an City, Shaanxi Province

经费或物资来源:

口颌系统重建与再生全国重点实验室自主研究课题(课题编号2021ZA03)

Source(s) of funding:

Independent research project of National Key Laboratory of Reconstruction and Regeneration of Oral and Maxillary System (Project No. 2021ZA03)

Target disease:

Oral and maxillofacial tissue defects

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

验证一种新型骨修复材料的小样本临床预试验研究--丝氨酸修饰明胶海绵用于口腔及颌面内组织修复的安全性和有效性  

Objectives of Study:

A small sample pre-clinical trial study to validate the safety and efficacy of a novel bone repair material, serine modified gelatin sponge, for oral and maxillofacial tissue repair

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)年龄在18-50岁之间,性别不限;(2)因重度牙周炎需要拔除的患牙;探诊深度>6mm;附着丧失≥5 mm;牙槽骨吸收超过根长的1/2;后牙有Ⅱ度及以上根分叉病变;(3)至少剩余2个骨壁,骨壁的剩余高度≥3mm;(4)可以保证术后4个随访点完整(术后1月、3月、6月、1年);(5)至少存在一颗邻牙;(6)经过牙周基础治疗,能够保持良好的口腔卫生状况.患者均同意参加实验,已签署知情同意书;(7)无明显手术禁忌者。

Inclusion criteria

(1) Age between 18 and 50 years old, regardless of gender; (2) Affected teeth that need to be removed due to severe periodontitis; Probing depth >6mm; Loss of attachment ≥5 mm; Alveolar bone resorption exceeds 1/2 root length; The posterior teeth had root bifurcation lesions of degree Ⅱ and above. (3) There are at least 2 remaining bone walls, and the remaining height of the bone wall is ≥3mm; (4) The four follow-up points can be guaranteed to be complete (1 month, 3 months, 6 months, 1 year after surgery); (5) The presence of at least one adjacent tooth; (6) After periodontal basic treatment, can maintain good oral health condition. All patients agreed to participate in the experiment and have signed informed consent; (7) Patients with no obvious surgical contraindications.

排除标准:

(1)过敏体质;(2)患牙处于急性感染期;(3)有全身系统性疾病或传染病史;(4)长期服用皮质类固醇,非甾体类抗炎药及双磷酸盐等影响骨代谢的相关药物;(5)患者在怀孕或备孕期间;(6)有头颈部放疗史;(7)不能保证按时治疗,未能合作者;(8)出现了对试验结果有影响的疾病;(9)心理疾病患者。

Exclusion criteria:

(1) Allergic constitution; (2) The affected tooth is in the acute infection stage; (3) Have a history of systemic disease or infection; (4) Long-term use of corticosteroids, non-steroidal anti-inflammatory drugs, bisphosphonates and other related drugs that affect bone metabolism; (5) The patient is pregnant or preparing for pregnancy; (6) History of head and neck radiotherapy; (7) can not guarantee timely treatment, no partner; (8) There is a disease that has an impact on the test results; (9) Patients with mental illness.

研究实施时间:

Study execute time:

From 2024-10-30 00:00:00 To 2026-10-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-10-30 00:00:00 To 2025-10-30 00:00:00  

干预措施:

Interventions:

组别:

试验组

样本量:

10

Group:

Experimental group

Sample size:

干预措施:

新型骨修复材料--丝氨酸修饰明胶海绵修复骨缺损

干预措施代码:

Intervention:

A new bone repair material - serine modified gelatin sponge for repairing bone defects

Intervention code:

组别:

对照组

样本量:

10

Group:

Control group

Sample size:

干预措施:

盖氏 Bio-Oss Collagen骨填充材料/骨胶原

干预措施代码:

Intervention:

Guy's Bio-Oss Collagen bone filling materials/collagen

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

陕西 

市(区县):

 

Country:

China 

Province:

Shaanxi 

City:

 

单位(医院):

空军军医大学第三附属医院  

单位级别:

三甲  

Institution
hospital:

Air Force Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

拔牙窝缺损愈合率

指标类型:

主要指标

Outcome:

The healing rate of tooth cavity defect

Type:

Primary indicator

测量时间点:

术后1个月、3个月、6个月、12个月

测量方法:

Measure time point of outcome:

1 month, 3 months, 6 months, 12 months after surgery

Measure method:

指标中文名:

手术区域满意度

指标类型:

次要指标

Outcome:

Surgical area satisfaction

Type:

Secondary indicator

测量时间点:

术后12个月

测量方法:

Measure time point of outcome:

12 months post-operation

Measure method:

指标中文名:

试验整体质量控追踪

指标类型:

主要指标

Outcome:

Overall quality control and tracking of the test

Type:

Primary indicator

测量时间点:

术后1个月、3个月、6个月、12个月

测量方法:

Measure time point of outcome:

1 month, 3 months, 6 months, 12 months after surgery

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

NA

组织:

Sample Name:

NA

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 50 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

使用中央随机系统进行随机

Randomization Procedure (please state who generates the random number sequence and by what method):

Randomization using a central randomization system

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

单盲:施盲对象为受试者人员。

Blinding:

Single-blind: The blinding object is the subject person.

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

NA

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

NA

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

EDC

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2024-10-20 01:00:35